Skip to main content
新芝生物 logo

新芝生物 — Investor Relations & Filings

Ticker · 920685 Beijing Stock Exchange Manufacturing
Filings indexed 390 across all filing types
Latest filing 2024-12-15 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920685

About 新芝生物

https://www.scientz.com/

Scientz Biotechnology specializes in the design and manufacture of high-performance life science instruments and laboratory equipment. The product range features ultrasonic cell disruptors, freeze dryers, gene guns, and high-pressure homogenizers, which are essential for sample preparation, cell lysis, and genetic engineering. The company also provides specialized solutions for tissue grinding, ultrasonic cleaning, and precise temperature control. These instruments serve a broad spectrum of applications in molecular biology, pharmaceutical research, environmental science, and agricultural technology. By integrating advanced ultrasonic and cryogenic technologies, Scientz supports research institutions and industrial laboratories in achieving accurate and reproducible results across various scientific disciplines.

Recent filings

Filing Released Lang Actions
关于控股子公司对外投资设立全资子公司并取得营业执照的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Ningbo New Zhi Biological Technology Co., Ltd. regarding its controlling subsidiary's external investment to establish a wholly-owned subsidiary and obtain a business license. It details the investment overview, confirms it is not a major asset restructuring or related party transaction, and describes the investment's purpose, risks, and impact on the company. The document is relatively short (1891 characters) and serves as a formal notification of a corporate investment event rather than a financial report or detailed management discussion. It does not contain financial statements, earnings data, or detailed analysis. It is not a report publication announcement since it contains substantive information about the investment. The content fits best with a Capital/Financing Update (CAP) as it relates to company fundraising, financing activities, or capital structure changes, specifically the establishment of a new subsidiary through investment.
2024-12-15 Chinese
关于使用部分闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from Ningbo New Gen Bio-tech Co., Ltd. regarding the progress of using part of idle raised funds for cash management. It includes specifics about authorized cash management, types of financial products used, amounts, expected yields, risk controls, and internal approvals. The document is an update on the company's financing activities related to the use of idle raised funds, focusing on cash management products and their status. It is not a full financial report, earnings release, or audit report. It is also not a regulatory filing or announcement of a report publication. The content fits best under Capital/Financing Update (CAP) as it provides updates on the company's fundraising and capital usage activities, specifically the management of idle raised funds through financial products.
2024-12-11 Chinese
关于使用部分闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from Ningbo Xinzhi Biotechnology Co., Ltd. regarding the progress of using part of idle raised funds for cash management. It includes specifics about authorized cash management, types of financial products used, amounts, expected yields, risk controls, and internal approvals. The document is an update on the company's financing activities related to the management of idle raised funds, not a full financial report or earnings release. It does not contain comprehensive financial statements or quarterly/yearly financial results. It is not a regulatory certification or a report publication announcement but a substantive update on capital management activities. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length (over 10,000 characters) and detailed content support this classification with high confidence.
2024-11-26 Chinese
控股股东增持股份结果公告
Major Shareholding Notification Classification · 100% confidence The document is a formal announcement regarding the results of a controlling shareholder's share increase (shareholding increase). It details the shareholder's identity, the number of shares held before and after the increase, the plan and its implementation results, including dates, prices, and amounts. There is no financial report, earnings data, or management discussion. The document is a notification of a change in major shareholding levels, consistent with the definition of Major Shareholding Notification (MRQ). The document length is short and focused solely on shareholding changes, not a full report or announcement of a report publication.
2024-11-19 Chinese
股票解除限售公告
Share Issue/Capital Change Classification · 95% confidence The document is a formal announcement regarding the lifting of trading restrictions on a specific number of shares held by certain shareholders, including details about the number of shares, shareholder identities, reasons for lifting restrictions, and subsequent shareholding structure. It includes legal assurances about the accuracy of the announcement and references to regulatory compliance and shareholder commitments. The document does not contain financial statements, earnings data, or detailed management discussion. It is a regulatory announcement about share status changes, specifically the removal of share lock-up restrictions, which fits the category of Share Issue/Capital Change (SHA) as it relates to changes in share capital availability and trading status.
2024-11-13 Chinese
关于持股5%以上股东、董事完成股份非交易过户的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a notification about a non-trade transfer of shares between shareholders and directors, specifically involving shareholders holding more than 5% of the company's shares. It details the shareholding changes, confirms no change in control, and references regulatory rules about shareholding and disclosure. The document is an announcement of a shareholding change by significant shareholders and directors, not a financial report or earnings release. It fits the definition of a Major Shareholding Notification (MRQ) as it reports changes in significant share ownership levels crossing thresholds.
2024-11-07 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.